IL-17–targeting biologics aim to become standard of care in psoriasis

被引：0
|
作者：
Mark Ratner
机构：
来源：
Nature Biotechnology | 2015年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：1
相关论文
共 50 条
  • [41] Neutrophil is not the dominant IL-17 producer in psoriasis
    Yamanaka, K.
    Yamagiwa, A.
    Akeda, T.
    Kondo, M.
    Kakeda, M.
    Habe, K.
    Mizutani, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S30 - S30
  • [42] The contribution of IL-17 to the development of autoimmunity in psoriasis
    Furue, Masutaka
    Kadono, Takafumi
    INNATE IMMUNITY, 2019, 25 (06) : 337 - 343
  • [43] Is neutrophil the dominant IL-17 producer in psoriasis?
    Mizutani, K.
    Matsushima, Y.
    Okada, K.
    Yamagiwa, A.
    Akeda, T.
    Kondo, M.
    Kakeda, M.
    Habe, K.
    Yamanaka, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S257 - S257
  • [44] Elements and effects of IL-17 pathway in psoriasis
    Witte, E.
    Wolk, K.
    Christou, D.
    Witte, K.
    Philipp, S.
    Kokolakis, G.
    Volk, H.
    Sterry, W.
    Sabat, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S233 - S233
  • [45] Pathogenicity and biomarkers of the IL-17 pathway in psoriasis
    Wolk, K.
    Witte, E.
    Christou, D.
    Witte, K.
    Philipp, S.
    Kokolakis, G.
    Volk, H.
    Sterry, W.
    Sabat, R.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E15 - E15
  • [46] Paradoxical psoriasis induced by IL-17 antagonists
    Wang, Yachen
    Yang, Fengling
    Wang, Ruizhe
    Luo, Suju
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (05): : 623 - 631
  • [47] Effect of IL-17 on an organotypic model of psoriasis
    Ayehunie, S.
    Landry, T.
    Stevens, Z.
    Hedin, C.
    Bachelor, M. A.
    Armento, A.
    Klausner, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S97 - S97
  • [48] Interleukin 17 (il-17) Targeting Therapy In Asthma
    Mahdavian, M.
    Ferrell, A.
    Asghari, S.
    Yi, Y.
    Aaron, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] Targeting the IL-17–TH17 pathway
    Hilary S. Bartlett
    Ryan P. Million
    Nature Reviews Drug Discovery, 2015, 14 : 11 - 12
  • [50] The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment
    ten Bergen, Lisa Lynn
    Petrovic, Aleksandra
    Aarebrot, Anders Krogh
    Appel, Silke
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (04)
12345